Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1987785rdf:typepubmed:Citationlld:pubmed
pubmed-article:1987785lifeskim:mentionsumls-concept:C0042449lld:lifeskim
pubmed-article:1987785lifeskim:mentionsumls-concept:C0699819lld:lifeskim
pubmed-article:1987785lifeskim:mentionsumls-concept:C0023401lld:lifeskim
pubmed-article:1987785lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:1987785pubmed:issue1 Pt 1lld:pubmed
pubmed-article:1987785pubmed:dateCreated1991-2-21lld:pubmed
pubmed-article:1987785pubmed:abstractTextIn amino acid tracer kinetic studies of the fed state, ingested amino acid may be taken up during its initial transit through splanchnic tissues and thus not enter the plasma compartment where tracer is infused. To investigate this possibility, adult human subjects received simultaneous intravenous (iv) and intragastric (ig) leucine tracer infusions, first during a postabsorptive (PA) 4-h primed continuous ig infusion of L-[1-13C]-leucine and L-[5,5,5-2H3]leucine iv, followed on a separate day by a fed infusion, in which an ig infusion of a liquid formula was started 2 h before the tracer infusion and continued throughout the tracer study. Subjects were accustomed to a constant experimental diet supplying 1.5 g protein.kg-1.day-1 and 41-45 kcal.kg-1.day-1 for 7 and 12 days before the PA and fed studies, respectively. For the PA study, plasma enrichment for the ig tracer was 3.34 +/- 0.27 (SE) mol + excess and for the iv tracer it was 4.18 +/- 0.10 (P less than 0.02). Enrichments of alpha-keto-isocaproic acid (KIC) were 3.24 +/- 0.16 (ig) and 3.02 +/- 0.14 (iv), respectively [not significant (NS)]. For the fed study, plasma leucine enrichment for the ig tracer was 2.15 +/- 0.14 and for the iv tracer was 2.84 +/- 0.09 (P less than 0.02). KIC enrichments were 2.02 +/- 0.08 (ig) and 2.24 +/- 0.08 (iv), respectively (NS). In the PA study, the ratio of the plasma leucine enrichments for the ig and iv tracers was 0.80 +/- 0.06 and in the fed experiment, 0.76 +/- 0.05, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1987785pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:languageenglld:pubmed
pubmed-article:1987785pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:citationSubsetIMlld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1987785pubmed:statusMEDLINElld:pubmed
pubmed-article:1987785pubmed:monthJanlld:pubmed
pubmed-article:1987785pubmed:issn0002-9513lld:pubmed
pubmed-article:1987785pubmed:authorpubmed-author:YoungV RVRlld:pubmed
pubmed-article:1987785pubmed:authorpubmed-author:BierD MDMlld:pubmed
pubmed-article:1987785pubmed:authorpubmed-author:MatthewsD EDElld:pubmed
pubmed-article:1987785pubmed:authorpubmed-author:HoerrR ARAlld:pubmed
pubmed-article:1987785pubmed:issnTypePrintlld:pubmed
pubmed-article:1987785pubmed:volume260lld:pubmed
pubmed-article:1987785pubmed:ownerNLMlld:pubmed
pubmed-article:1987785pubmed:authorsCompleteYlld:pubmed
pubmed-article:1987785pubmed:paginationE111-7lld:pubmed
pubmed-article:1987785pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:meshHeadingpubmed-meshheading:1987785-...lld:pubmed
pubmed-article:1987785pubmed:year1991lld:pubmed
pubmed-article:1987785pubmed:articleTitleLeucine kinetics from [2H3]- and [13C]leucine infused simultaneously by gut and vein.lld:pubmed
pubmed-article:1987785pubmed:affiliationLaboratory of Human Nutrition, School of Science, Massachusetts Institute of Technology, Cambridge 02139.lld:pubmed
pubmed-article:1987785pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1987785pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1987785lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1987785lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1987785lld:pubmed